Aspire Biopharma Holdings, Inc. has filed an amendment to its certificate of incorporation to change its corporate name to Aspire-Lakewood Holdings, Inc., effective September 8, 2026. The filing states that the name change was made pursuant to Section 212 and 242 of the General Corporation Law of the State of Delaware and did not require stockholder approval. The company’s common stock will continue to trade on The Nasdaq Capital Market under the existing ticker symbol ASBP, and the CUSIP number remains unchanged.
In a press release dated September 9, 2026, the company announced that its Board of Directors has authorized a $10 million common stock repurchase program. This authorization reflects the leadership’s view that the company’s share price does not reflect its financial strength or long-term growth opportunity. The repurchase program is effective September 9, 2026.
The company attributes its confidence in the program to the financial performance of its subsidiary, Dura Control Systems Corp. (DCSC). For the audited twelve months ended December 31, 2025, DCSC generated revenue of approximately $209.5 million and Adjusted EBITDA of $22.3 million. For the six months ended June 30, 2026, DCSC delivered revenue of approximately $103.9 million and Adjusted EBITDA of $10.5 million. As of September 8, 2026, the company reported approximately 1.5 million common shares outstanding.
Aspire-Lakewood Holdings describes DCSC as a premier tier-one global automotive supplier with a 100+ year legacy specializing in high-margin electronic and mechanical control systems. The company operates 11 manufacturing facilities globally and serves as a tier-one automotive supplier to major OEMs. Aspire-Lakewood Holdings is also developing a patent-pending delivery technology for pharmaceuticals and other bioactive substances.
